Kingdon Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Kingdon Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260,118	Closed	-$5.01M	–	99
2022 Q1	$5.01M	Buy	260,118 +86,288	+50%	+$1.79M	0.52%	47
2021 Q4	$4.12M	Hold	173,830	–	–	0.47%	53
2021 Q3	$3.48M	Buy	+173,830	New	+$3.73M	0.42%	43

Other funds holding IMGO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Kingdon Capital Management's IMGO Position: Q2 2022 in Review

Kingdon Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q2 2022, closing a stake of 260,118 shares — an estimated $5.01M sold.

Kingdon Capital Management first reported a position in IMGO in Q3 2021 and held it in 3 quarters. The position peaked at $5.01M in Q1 2022. 62 funds tracked by Wall St. Rank hold IMGO as of Q2 2022.

Kingdon Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q2 2022 after selling out during the quarter.
Kingdon Capital Management sold 260,118 Imago BioSciences, Inc. Common stock shares in Q2 2022, an estimated $5.01M.
Kingdon Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 3 quarters.
Kingdon Capital Management's Imago BioSciences, Inc. Common stock position peaked at $5.01M in Q1 2022.
62 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q2 2022.

Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.